CA2181165A1 - Anti-fungal methods and materials - Google Patents
Anti-fungal methods and materialsInfo
- Publication number
- CA2181165A1 CA2181165A1 CA002181165A CA2181165A CA2181165A1 CA 2181165 A1 CA2181165 A1 CA 2181165A1 CA 002181165 A CA002181165 A CA 002181165A CA 2181165 A CA2181165 A CA 2181165A CA 2181165 A1 CA2181165 A1 CA 2181165A1
- Authority
- CA
- Canada
- Prior art keywords
- materials
- methods
- fungal methods
- fungal
- fungal infection
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4742—Bactericidal/Permeability-increasing protein [BPI]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Abstract
The present invention relates to methods for treating fungal infection comprising administering to a subject suffering from a fungal infection a bactericidal/permeability (BPI) protein product.
Applications Claiming Priority (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US18322294A | 1994-01-14 | 1994-01-14 | |
US08/183,222 | 1994-01-14 | ||
US08/209,762 | 1994-03-11 | ||
US08/209,762 US5733872A (en) | 1993-03-12 | 1994-03-11 | Biologically active peptides from functional domains of bactericidal/permeability-increasing protein and uses thereof |
US27354094A | 1994-07-11 | 1994-07-11 | |
US08/273,540 | 1994-07-11 | ||
PCT/US1995/000498 WO1995019179A1 (en) | 1994-01-14 | 1995-01-13 | Anti-fungal methods and materials |
Publications (2)
Publication Number | Publication Date |
---|---|
CA2181165A1 true CA2181165A1 (en) | 1995-07-20 |
CA2181165C CA2181165C (en) | 2007-06-05 |
Family
ID=27391654
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002181165A Expired - Fee Related CA2181165C (en) | 1994-01-14 | 1995-01-13 | Anti-fungal methods and materials |
Country Status (11)
Country | Link |
---|---|
US (1) | US5627153A (en) |
EP (1) | EP0754049B1 (en) |
JP (1) | JPH09508357A (en) |
CN (1) | CN1112933C (en) |
AT (1) | ATE215379T1 (en) |
AU (1) | AU703211B2 (en) |
CA (1) | CA2181165C (en) |
DE (1) | DE69526216T2 (en) |
HK (1) | HK1014158A1 (en) |
MX (1) | MX9602570A (en) |
WO (1) | WO1995019179A1 (en) |
Families Citing this family (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6117974A (en) * | 1991-10-02 | 2000-09-12 | Peptor Limited | Libraries of backbone-cyclized peptidomimetics |
US5652332A (en) * | 1993-03-12 | 1997-07-29 | Xoma | Biologically active peptides from functional domains of bactericidal/permeability-increasing protein and uses thereof |
US5447913A (en) | 1994-03-11 | 1995-09-05 | Xoma Corporation | Therapeutic uses of bactericidal/permeability-increasing protein dimer products |
JPH10508576A (en) * | 1994-09-15 | 1998-08-25 | ゾーマ コーポレイション | Antifungal peptide |
JP2001520631A (en) * | 1995-07-20 | 2001-10-30 | ゾーマ コーポレイション | Antifungal peptide |
US5851802A (en) * | 1996-03-22 | 1998-12-22 | Xoma Corporation | Methods for recombinant microbial production of fusion proteins and BPI-derived peptides |
DE69703689T2 (en) * | 1996-05-10 | 2001-05-10 | Xoma Technology Ltd | THERAPEUTIC APPLICATIONS OF BPI PROTEIN PRODUCTS FOR TREATING HUMAN MENINGOCOCCÄMIA |
US5741779A (en) | 1996-05-10 | 1998-04-21 | Xoma Corporation | Antithrombotic materials and methods |
AU736096B2 (en) * | 1996-05-23 | 2001-07-26 | Xoma Corporation | Therapeutic uses of BPI protein products in humans with hemorrhage due to trauma |
US5888973A (en) * | 1996-08-09 | 1999-03-30 | Xoma Corporation | Anti-chlamydial uses of BPI protein products |
USRE38984E1 (en) * | 1996-09-12 | 2006-02-14 | Merck & Co., Inc. | Antifungal combination therapy |
US6482796B2 (en) * | 1996-11-01 | 2002-11-19 | Xoma Corporation | Therapeutic uses of N-terminal BPI protein products in ANCA-positive patients |
US6093573A (en) * | 1997-06-20 | 2000-07-25 | Xoma | Three-dimensional structure of bactericidal/permeability-increasing protein (BPI) |
US6013631A (en) * | 1998-06-19 | 2000-01-11 | Xoma Corporation | Bactericidal/permeability-increasing protein (BPI) deletion analogs |
JP2004517865A (en) * | 2000-12-01 | 2004-06-17 | ゾーマ テクノロジー リミテッド | Regulation of pericyte proliferation using BPI protein products or inhibitors |
US7270975B2 (en) * | 2001-03-09 | 2007-09-18 | Trustees Of Dartmouth College | Methods for regulating bud-hypha transitions and cAMP levels in Candida albicans |
US6706688B2 (en) | 2001-03-09 | 2004-03-16 | Paula Sundstrom | Methods for regulating bud-hypha transitions and cAMP levels by the adenylate cyclase-associated protein gene, CAP1 |
EA012569B1 (en) * | 2004-02-24 | 2009-10-30 | Коммонвелт Сайентифик Энд Индастриал Рисёч Организейшн | Insect peptide having antifungal and/or antibacterial activity and methods of using thereof |
WO2006120496A1 (en) * | 2005-05-13 | 2006-11-16 | Advanced Scientific Developements | Pharmaceutical combination comprising an antifungal agent and an active substance selected from carveol, eugenol, thymol, borneol and carvacrol |
EP1741440A1 (en) | 2005-07-08 | 2007-01-10 | Mellitus S.L. | Use of BPI protein for the treatment of disorders of the metabolism and cardiovascular disorders |
US8771693B2 (en) | 2009-10-27 | 2014-07-08 | Beth Israel Deaconess Medical Center, Inc. | Methods and compositions for the generation and use of conformation-specific antibodies |
WO2012149334A2 (en) | 2011-04-27 | 2012-11-01 | Beth Israel Deaconess Medical Center, Inc. | Methods and compositions for the generation and use of conformation-specific antibodies |
GB201319621D0 (en) | 2013-11-06 | 2013-12-18 | Norwegian University Of Science And Technology | Antimicrobial agents and their use in therapy |
GB201319620D0 (en) | 2013-11-06 | 2013-12-18 | Norwegian University Of Science And Technology | Immunosuppressive agents and their use in therapy |
CN104745595B (en) * | 2015-03-27 | 2017-06-27 | 宁波大学 | Stichopus japonicus BPI genes, encoding proteins and its cloning process and restructuring stichopus japonicus BPI construction of genetic engineering methods |
Family Cites Families (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5126257A (en) * | 1986-11-26 | 1992-06-30 | Cornell Research Foundation | Antimicrobial proteins, compositions containing same and uses thereof |
US5087569A (en) * | 1986-11-26 | 1992-02-11 | Cornell Research Foundation, Inc. And The Rockefeller University | Antimicrobial proteins, compositions containing same and uses thereof |
US5198541A (en) * | 1987-08-11 | 1993-03-30 | New York University | Dna encoding bactericidal/permeability-increasing proteins |
US5234912A (en) * | 1989-02-14 | 1993-08-10 | Incyte Pharmaceuticals, Inc. | Pharmaceutical compositions comprising recombinant BPI proteins and a lipid carrier and uses thereof |
US5308834A (en) * | 1989-02-14 | 1994-05-03 | Incyte Pharmaceuticals, Inc. | Treatment of endotoxin-associated shock and prevention thereof using a BPI protein |
US5171739A (en) * | 1989-02-14 | 1992-12-15 | Incyte Pharmaceuticals, Inc. | Treatment of endotoxin-associated shock and preventation thereof using a BPI protein |
US5089274A (en) * | 1989-02-14 | 1992-02-18 | Incyte Pharmaceuticals, Inc. | Use of bactericidal/permeability increasing protein or biologically active analogs thereof to treat endotoxin-related disorders |
US5334584A (en) * | 1989-02-14 | 1994-08-02 | Incyte Pharamaceuticals, Inc. | Recombinant, non-glycosylated bpi protein and uses thereof |
EP0563222B1 (en) * | 1990-12-03 | 1998-02-25 | New York University | Biologically active bactericidal/permeability-increasing protein fragments |
EP0605653A4 (en) * | 1991-09-26 | 1995-03-15 | Incyte Pharma Inc | A new form of liposaccharide binding protein (lbp). |
WO1993023540A2 (en) * | 1992-05-19 | 1993-11-25 | Xoma Corporation | Improved methods for the preparation of endotoxin-binding proteins |
US5643570A (en) * | 1992-05-19 | 1997-07-01 | Xoma Corporation | BPI-immunoglobulin fusion proteins |
EP0682524B1 (en) * | 1993-02-02 | 2001-10-04 | XOMA Technology Ltd. | Pharmaceutical compositions containing bactericidal permeability increasing protein and a surfactant |
US5420019A (en) * | 1993-02-02 | 1995-05-30 | Xoma Corporation | Stable bactericidal/permeability-increasing protein muteins |
MX9401807A (en) * | 1993-03-12 | 1995-01-31 | Xoma Corp | THERAPEUTIC USES OF PROTEIN PRODUCTS THAT INCREASE PERMEABILITY / BACTERICIDES. |
ATE165976T1 (en) * | 1993-03-12 | 1998-05-15 | Xoma Corp | TREATMENT OF MYCOBACTERIAL DISEASES BY ADMINISTRATION OF BACRERIACIDAL, PERMEABILITY-INCREASE PROTEIN FRAGMENTS |
US5348942A (en) * | 1993-03-12 | 1994-09-20 | Xoma Corporation | Therapeutic uses of bactericidal/permeability increasing protein products |
AU694108B2 (en) * | 1993-03-12 | 1998-07-16 | Xoma Corporation | Biologically active peptides from functional domains of bactericidal/permeability-increasing protein and uses thereof |
US5447913A (en) * | 1994-03-11 | 1995-09-05 | Xoma Corporation | Therapeutic uses of bactericidal/permeability-increasing protein dimer products |
-
1995
- 1995-01-13 EP EP95908502A patent/EP0754049B1/en not_active Expired - Lifetime
- 1995-01-13 WO PCT/US1995/000498 patent/WO1995019179A1/en active IP Right Grant
- 1995-01-13 MX MX9602570A patent/MX9602570A/en unknown
- 1995-01-13 CA CA002181165A patent/CA2181165C/en not_active Expired - Fee Related
- 1995-01-13 JP JP7519144A patent/JPH09508357A/en not_active Ceased
- 1995-01-13 AT AT95908502T patent/ATE215379T1/en not_active IP Right Cessation
- 1995-01-13 CN CN95191676A patent/CN1112933C/en not_active Expired - Fee Related
- 1995-01-13 US US08/372,105 patent/US5627153A/en not_active Expired - Lifetime
- 1995-01-13 DE DE69526216T patent/DE69526216T2/en not_active Expired - Fee Related
- 1995-01-13 AU AU16797/95A patent/AU703211B2/en not_active Ceased
-
1998
- 1998-12-24 HK HK98115459A patent/HK1014158A1/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
EP0754049A1 (en) | 1997-01-22 |
JPH09508357A (en) | 1997-08-26 |
CA2181165C (en) | 2007-06-05 |
US5627153A (en) | 1997-05-06 |
AU1679795A (en) | 1995-08-01 |
HK1014158A1 (en) | 1999-09-24 |
EP0754049B1 (en) | 2002-04-03 |
DE69526216T2 (en) | 2002-11-14 |
ATE215379T1 (en) | 2002-04-15 |
AU703211B2 (en) | 1999-03-18 |
MX9602570A (en) | 1997-04-30 |
DE69526216D1 (en) | 2002-05-08 |
CN1140999A (en) | 1997-01-22 |
WO1995019179A1 (en) | 1995-07-20 |
CN1112933C (en) | 2003-07-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2181165A1 (en) | Anti-fungal methods and materials | |
CA2115348A1 (en) | Process for the production of pharmaceutical preparations containing human protein for infusion or injection purposes | |
CA2275392A1 (en) | New aqueous medicament preparations for the production of propellent gas-free aerosols | |
CA2263181A1 (en) | Anti-chlamydial methods and materials | |
AU8154694A (en) | Methods of increasing TGF-13 in the brain, inhibiting Alzeheimers disease and inhibiting B-amyloid peptide mediated neurotoxicity. | |
CA2223505A1 (en) | Anti-fungal and anti-bacterial histatin-based peptides | |
CA2154424A1 (en) | 1-phenyl-3-dimethylaminopropane compounds having a pharmaceutical effect | |
AU2455295A (en) | Protein or polypeptide, process for producing the same, and intermediate compound tehrefor | |
CA2235625A1 (en) | Bactericidal/permeability increasing protein (bpi) for treating conditions associated with corneal transplantation | |
BG101131A (en) | 2-oxo-and 2-thio-1,2-dihydroquinolinyl-oxazolidinons | |
AU4770596A (en) | Improved therapeutic compositions comprising bactericidal/permeability-increasing (bpi) protein products | |
AU2967595A (en) | Anti-protozoan methods and materials | |
ZA965752B (en) | Triphenylethylenes, process for their production, pharmaceutical preparations that contain these triphenylethylenes as well as their use for the production of pharmaceutical agents. | |
CA2340728A1 (en) | Methods of treating hypertension and compositions for use therein | |
ZA976967B (en) | Device and process for separating magnetic materials from pharmaceutical preparations, their starting or intermediate products, as well as agents that are produced with the of said device. | |
CA2173611A1 (en) | Method of treating depressed reticuloendothelial system function | |
CA2235626A1 (en) | Bactericidal permeability increasing protein (bpi) for treating conditions associated with corneal injury | |
WO2002046225A3 (en) | Use of sarp-1 for the treatment and/or prevention of scleroderma | |
AU4012795A (en) | Alzheimer's peptide | |
AU2548597A (en) | Antibodies against avirulence/pathogenicity proteins of plant pathogens | |
AU4674596A (en) | Complexes, processes for their preparation and their use | |
AU7561596A (en) | Azinooximethers, processes and intermediate products for manufacturing same, and the uses thereof in combating harmful fungi and pests | |
CA2194294A1 (en) | Complexes for use in the diagnosis of vascular diseases | |
AU2886595A (en) | Technetium-sulphonamide complexes, their use, pharmaceutical agents containing the latter, as well as process for the production of the complexes and agents | |
IL124344A0 (en) | Novel dithiazoldioxides and the use thereof as microbicides |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
MKLA | Lapsed |